US Stock MarketDetailed Quotes

ANTX AN2 Therapeutics

Watchlist

1.990
-0.050-2.45%

Close May 31 16:00 ET

1.990
0.0000.00%

Post 16:09 ET

59.36MMarket Cap-792P/E (TTM)

AN2 Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-51.72%-17.59M

-59.25%-53.29M

-123.46%-17.07M

-24.38%-11.8M

-33.65%-12.82M

-72.00%-11.6M

-63.36%-33.46M

15.07%-7.64M

-102.24%-9.49M

-82.52%-9.6M

Net income from continuing operations

-8.44%-16.62M

-58.05%-64.73M

-42.70%-16.9M

-47.34%-16.71M

-56.17%-15.8M

-100.17%-15.32M

-90.11%-40.96M

-56.95%-11.84M

-63.32%-11.34M

-102.12%-10.12M

Other non cash items

----

-31.17%53K

--0

-35.00%13K

10.53%21K

5.56%19K

--77K

--20K

--19K

Change In working capital

-209.40%-2.27M

56.91%5.83M

-135.50%-1.1M

297.88%3.38M

322.78%1.48M

366.29%2.08M

11,518.75%3.72M

262.13%3.09M

-54.82%849K

-50.68%-663K

-Change in prepaid assets

49.46%1.11M

38.86%-1.03M

-287.05%-621K

-96.69%21K

43.79%-1.17M

231.10%742K

-20.98%-1.68M

131.92%332K

4.11%634K

-96.41%-2.08M

-Change in payables and accrued expense

-324.33%-3.03M

14.14%6.25M

-104.72%-140K

1,221.52%1.77M

209.00%3.26M

-16.02%1.35M

489.13%5.47M

343.23%2.97M

-115.71%-158K

145.01%1.06M

-Change in other current liabilities

-1,721.05%-346K

896.10%613K

-1,435.00%-307K

4,900.00%960K

-10.53%-21K

-5.56%-19K

---77K

---20K

---19K

-Change in other working capital

----

59.03%625K

----

48.86%393K

102.14%378K

Cash from discontinued investing activities

Operating cash flow

-51.72%-17.59M

-59.25%-53.29M

-123.46%-17.07M

-24.38%-11.8M

-33.65%-12.82M

-72.00%-11.6M

-63.36%-33.46M

15.07%-7.64M

-102.24%-9.49M

-82.52%-9.6M

Investing cash flow

Cash flow from continuing investing activities

141.48%26.29M

-98.79%-43.28M

-93.06%420K

-2,595.81%-62.46M

119.95%7.88M

-22.11%10.89M

56.48%-21.77M

-3.06%6.06M

66.83%-2.32M

19.88%-39.49M

Net investment purchase and sale

141.48%26.29M

-98.79%-43.28M

-93.06%420K

-2,595.81%-62.46M

119.95%7.88M

-22.11%10.89M

56.48%-21.77M

-3.06%6.06M

66.83%-2.32M

19.88%-39.49M

Cash from discontinued investing activities

Investing cash flow

141.48%26.29M

-98.79%-43.28M

-93.06%420K

-2,595.81%-62.46M

119.95%7.88M

-22.11%10.89M

56.48%-21.77M

-3.06%6.06M

66.83%-2.32M

19.88%-39.49M

Financing cash flow

Cash flow from continuing financing activities

75.38%349K

20.81%84.99M

-321K

660,760.00%66.07M

165.39%19.05M

-99.69%199K

-10.42%70.36M

95.83%-10K

7.18M

Net common stock issuance

----

20.13%84.53M

---321K

658,100.00%65.8M

----

--70.37M

--0

---10K

--7.18M

Proceeds from stock option exercised by employees

75.38%349K

4,327.27%465K

--0

--266K

--0

1,909.09%199K

-200.00%-11K

--0

Cash from discontinued financing activities

Financing cash flow

75.38%349K

20.81%84.99M

---321K

660,760.00%66.07M

165.39%19.05M

-99.69%199K

-10.42%70.36M

--0

95.83%-10K

--7.18M

Net cash flow

Beginning cash position

-42.51%15.65M

125.01%27.22M

13.24%32.62M

0.48%40.81M

-67.63%26.71M

125.01%27.22M

197.22%12.1M

82.14%28.8M

46.47%40.62M

0.30%82.52M

Current changes in cash

1,873.73%9.05M

-176.52%-11.57M

-971.95%-16.97M

30.62%-8.2M

133.66%14.1M

-100.72%-510K

88.39%15.12M

57.40%-1.58M

0.86%-11.81M

23.17%-41.9M

End cash Position

-7.55%24.69M

-42.51%15.65M

13.24%32.62M

0.48%40.81M

-67.63%26.71M

125.01%27.22M

82.14%28.8M

46.47%40.62M

Free cash flow

-51.72%-17.59M

-59.25%-53.29M

-123.46%-17.07M

-24.38%-11.8M

-33.65%-12.82M

-72.00%-11.6M

-63.36%-33.46M

15.07%-7.64M

-102.24%-9.49M

-82.52%-9.6M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-51.72%-17.59M	-59.25%-53.29M	-123.46%-17.07M	-24.38%-11.8M	-33.65%-12.82M	-72.00%-11.6M	-63.36%-33.46M	15.07%-7.64M	-102.24%-9.49M	-82.52%-9.6M
Net income from continuing operations	-8.44%-16.62M	-58.05%-64.73M	-42.70%-16.9M	-47.34%-16.71M	-56.17%-15.8M	-100.17%-15.32M	-90.11%-40.96M	-56.95%-11.84M	-63.32%-11.34M	-102.12%-10.12M
Other non cash items	----	-31.17%53K	--0	-35.00%13K	10.53%21K	5.56%19K	--77K	--20K	--20K	--19K
Change In working capital	-209.40%-2.27M	56.91%5.83M	-135.50%-1.1M	297.88%3.38M	322.78%1.48M	366.29%2.08M	11,518.75%3.72M	262.13%3.09M	-54.82%849K	-50.68%-663K
-Change in prepaid assets	49.46%1.11M	38.86%-1.03M	-287.05%-621K	-96.69%21K	43.79%-1.17M	231.10%742K	-20.98%-1.68M	131.92%332K	4.11%634K	-96.41%-2.08M
-Change in payables and accrued expense	-324.33%-3.03M	14.14%6.25M	-104.72%-140K	1,221.52%1.77M	209.00%3.26M	-16.02%1.35M	489.13%5.47M	343.23%2.97M	-115.71%-158K	145.01%1.06M
-Change in other current liabilities	-1,721.05%-346K	896.10%613K	-1,435.00%-307K	4,900.00%960K	-10.53%-21K	-5.56%-19K	---77K	---20K	---20K	---19K
-Change in other working capital	----	----	----	59.03%625K	----	----	----	----	48.86%393K	102.14%378K
Cash from discontinued investing activities
Operating cash flow	-51.72%-17.59M	-59.25%-53.29M	-123.46%-17.07M	-24.38%-11.8M	-33.65%-12.82M	-72.00%-11.6M	-63.36%-33.46M	15.07%-7.64M	-102.24%-9.49M	-82.52%-9.6M
Investing cash flow
Cash flow from continuing investing activities	141.48%26.29M	-98.79%-43.28M	-93.06%420K	-2,595.81%-62.46M	119.95%7.88M	-22.11%10.89M	56.48%-21.77M	-3.06%6.06M	66.83%-2.32M	19.88%-39.49M
Net investment purchase and sale	141.48%26.29M	-98.79%-43.28M	-93.06%420K	-2,595.81%-62.46M	119.95%7.88M	-22.11%10.89M	56.48%-21.77M	-3.06%6.06M	66.83%-2.32M	19.88%-39.49M
Cash from discontinued investing activities
Investing cash flow	141.48%26.29M	-98.79%-43.28M	-93.06%420K	-2,595.81%-62.46M	119.95%7.88M	-22.11%10.89M	56.48%-21.77M	-3.06%6.06M	66.83%-2.32M	19.88%-39.49M
Financing cash flow
Cash flow from continuing financing activities	75.38%349K	20.81%84.99M	-321K	660,760.00%66.07M	165.39%19.05M	-99.69%199K	-10.42%70.36M	0	95.83%-10K	7.18M
Net common stock issuance	----	20.13%84.53M	---321K	658,100.00%65.8M	----	----	--70.37M	--0	---10K	--7.18M
Proceeds from stock option exercised by employees	75.38%349K	4,327.27%465K	--0	--266K	--0	1,909.09%199K	-200.00%-11K	--0	--0	--0
Cash from discontinued financing activities
Financing cash flow	75.38%349K	20.81%84.99M	---321K	660,760.00%66.07M	165.39%19.05M	-99.69%199K	-10.42%70.36M	--0	95.83%-10K	--7.18M
Net cash flow
Beginning cash position	-42.51%15.65M	125.01%27.22M	13.24%32.62M	0.48%40.81M	-67.63%26.71M	125.01%27.22M	197.22%12.1M	82.14%28.8M	46.47%40.62M	0.30%82.52M
Current changes in cash	1,873.73%9.05M	-176.52%-11.57M	-971.95%-16.97M	30.62%-8.2M	133.66%14.1M	-100.72%-510K	88.39%15.12M	57.40%-1.58M	0.86%-11.81M	23.17%-41.9M
End cash Position	-7.55%24.69M	-42.51%15.65M	-42.51%15.65M	13.24%32.62M	0.48%40.81M	-67.63%26.71M	125.01%27.22M	125.01%27.22M	82.14%28.8M	46.47%40.62M
Free cash flow	-51.72%-17.59M	-59.25%-53.29M	-123.46%-17.07M	-24.38%-11.8M	-33.65%-12.82M	-72.00%-11.6M	-63.36%-33.46M	15.07%-7.64M	-102.24%-9.49M	-82.52%-9.6M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall